Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[REM Sleep behavioral disorder].

F Portet1, J Touchon

  • 1Unité de Neurologie comportementale et dégénérative, service de Neurologie B, CHU Gui de Chauliac, 80, rue Auguste Fliche, 34295 Montpellier Cedex, France.

Revue Neurologique
|November 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives.

The journal of prevention of Alzheimer's disease·2024
Same author

Editorial: What Is Reasonable and Necessary for Alzheimer Patients from Randomized Clinical Trials to Clinical Practice?

The journal of prevention of Alzheimer's disease·2023
Same author

The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report.

The journal of prevention of Alzheimer's disease·2022
Same author

Can We Distinguish Age-Related Frailty from Frailty Related to Diseases ? Data from the MAPT Study.

The journal of nutrition, health & aging·2020
Same author

Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report.

The journal of prevention of Alzheimer's disease·2020
Same author

Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force.

The journal of prevention of Alzheimer's disease·2019
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Rapid eye movement sleep behavior disorder (RBD) involves acting out dreams due to lost muscle paralysis during REM sleep. This condition often signals underlying neurodegenerative diseases, particularly those with parkinsonism.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Parasomnias

Context:

  • Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by the loss of skeletal muscle atonia during REM sleep.
  • This loss results in the enactment of dream content, often leading to violent behaviors and potential injuries.

Purpose:

  • To define Rapid eye movement sleep behavior disorder (RBD) and its clinical presentation.
  • To explore the association between RBD and neurological disorders, especially neurodegenerative conditions with parkinsonism.
  • To discuss the diagnostic criteria and potential predictive value of RBD.

Summary:

  • RBD is diagnosed via polysomnography, which reveals the absence of REM sleep atonia and associated abnormal behaviors.
  • While etiological factors are not fully understood, RBD is linked to drug use, toxic exposures, and frequently precedes symptoms of neurodegenerative diseases like Lewy body dementia.

Related Experiment Videos

  • Biochemical underpinnings may involve dopamino-cholinergic and serotonergic pathways.

    • Impact:

    • Highlights RBD as a significant clinical manifestation requiring polysomnographic diagnosis.
    • Emphasizes the predictive value of RBD for neurodegenerative disorders, particularly parkinsonian syndromes.
    • Underscores the need for further research into the biochemical mechanisms of RBD.